In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin–epichlorohydrin polymers

References

• Adel MA, Mazen KQ, Mahrous OA. (2003). Enhancement of dissolution rate and bioavailability of glipizide through cyclodextrin inclusion complex. Pharm Technol 27:54–62.
   Google Scholar
• Bekers O, Uijtendaal EV, Beijnen JH, Buit A, Underberg WJM. (1991). Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 17:1503–1549.
   Web of Science ®Google Scholar
• Bhosale AV, Hardikar SR, Jagtap RS, Patil NB, Dhawale SS, Shirsath SC. (2009). Formulation of beta cyclodextrin complexed controlled release matrix tablet of glipizide and its in-vitro evaluation. Int J Pharm Tech Res 1:773–778.
   Google Scholar
• Duchêne D. (1987). Cyclodextrin and Their Industrial Uses. Editions de Santé, Paris.
   Google Scholar
• Fenyvesi E. (1988). Cyclodextrin polymers in the pharmaceutical industry. J Incl Phenom 6:537–545.
   Web of Science ®Google Scholar
• Gan Y, Pan W, Wei M, Zhang R. (2002). Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Dev Ind Pharm 28:1015–1021.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. (1965). Phase-solubility techniques. Adv Anal Chem Instrum 4:117–212.
   Google Scholar
• Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147–162.
   PubMed Web of Science ®Google Scholar
• Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol 27:48–49.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017–1025.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Fridriksdottir H, Sigurdardottir AM. (1994). The effect of water-soluble polymers on drug–cyclodextrin complexation. Int J Pharm 110:169–177.
   Web of Science ®Google Scholar
• Marcus EB, Roger V, Peeters J, Peter N, Geert V, Thorsteinn L. (2008). Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci 3:494–103.
   Google Scholar
• Mura P, Faucci MT, Maestrelli F, Furlanetto S, Pinzauti S. (2002). Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin–epichlorohydrin polymers. J Pharm Biomed Anal 29:1015–1024.
   PubMed Web of Science ®Google Scholar
• Ozkan Y, Atay T, Dikmen N, Isimer A, Aboul-Enein HY. (2000). Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin. Pharm Acta Helv 74:365–370.
   PubMedGoogle Scholar
• Peeter J, Neeskens P, Adriaensen J, Brewster M. (2002). Effect of temperature on complexation with 2-hydroxypropyl-β-cyclodextrin. J Incl Phenom Mol 44:75–77.
   Web of Science ®Google Scholar
• Rajan K, Verma1 SG. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur J Pharm Biopharm 57:513–525.
   PubMed Web of Science ®Google Scholar
• Rajewski RA, Stella VJ. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142–1169.
   PubMed Web of Science ®Google Scholar
• Renard E, Deratani A, Volet G, SebilleB. (1997). Preparation and characterization of water soluble high molecular weight β-cyclodextrin–epichlorohydrin polymers. Eur Polym J 33:49–57.
   Web of Science ®Google Scholar
• Robert O, Vorapann M, Mongkol S. (1998). Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm 46:355–360.
   PubMed Web of Science ®Google Scholar
• Savolainen J, Jarvinun K, Matilainen L. (1998). Improved dissolution and bioavailability of phenytoin by sulfobutylether-cyclodextrin ((SBE)7m-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) complexation. Int J Pharm 165:69–78.
   Web of Science ®Google Scholar
• Stella VJ, Rajewski RA. (1997). Cyclodextrins: their future in drug formulation and delivery. Pharm Res 14:556–567.
   PubMed Web of Science ®Google Scholar
• Szejtli J. (1994). Medicinal applications of cyclodextrins. Med Res Rev 14:353–386.
   PubMed Web of Science ®Google Scholar
• Szeman J, Ueda H, Szejtli J, Fenyvesi E, Machida Y, Nagai T. (1987). Complexation of several drugs with water-soluble cyclodextrin polymer. Chem Pharm Bull 35:282–288.
   PubMed Web of Science ®Google Scholar
• Szente L, Szejtli J. (1999). Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev 36:17–28.
   PubMed Web of Science ®Google Scholar
• Tan FP, Jiang TM, Jiang GQ. (2004). Preparation and physicochemical properties of glipizide-β-cyclodextrin inclusion complex. Fine Chemicals 21:191–194.
   Google Scholar
• Thompson DO. (1997). Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1–104.
   PubMed Web of Science ®Google Scholar
• Uekama K, Otagiri M, Irie T, Seo H, Tsuruoka M. (1985). Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble cyclodextrin–epichlorohydrin polymer. Int J Pharm 23:35–42.
   Web of Science ®Google Scholar
• Ventura VA, Tirendi S, Puglisi G, Bousquet E. (1997). Improvement of water solubility and dissolution rate of ursodeoxychilic acid and chenodeoxychilic acid by complexation with natural and modified cyclodextrins. Int J Pharm 149:1–13.
   Web of Science ®Google Scholar
• Zhang YM, Li X, Sun CS, Chen CF. (2008). The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex. Guang Pu Xue Yu Guang Pu Fen Xi 28:711–714.
   PubMedGoogle Scholar